← Product Code [DWZ](/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/DWZ) · K921401

# BIOPSY FORCEPS (K921401)

_Annex Medical, Inc. · DWZ · Oct 21, 1992 · Cardiovascular · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/DWZ/K921401

## Device Facts

- **Applicant:** Annex Medical, Inc.
- **Product Code:** [DWZ](/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/DWZ.md)
- **Decision Date:** Oct 21, 1992
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 870.4075
- **Device Class:** Class 2
- **Review Panel:** Cardiovascular

## Regulatory Identification

An endomyocardial biopsy device is a device used in a catheterization procedure to remove samples of tissue from the inner wall of the heart.

---

**Source:** [https://fda.innolitics.com/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/DWZ/K921401](https://fda.innolitics.com/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/DWZ/K921401)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com